Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)
CUSIP: 21833P301
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 17,685,185
- Total 13F shares
- 749,666
- Share change
- +6,699
- Total reported value
- $4,528,896
- Price per share
- $6.04
- Number of holders
- 32
- Value change
- +$40,967
- Number of buys
- 9
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 21833P301?
CUSIP 21833P301 identifies CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21833P301:
Top shareholders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rachael Louise Brake |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
1,400,000
|
$6,958,000 | — | 13 Feb 2023 | |
| Craig Stuart Millian |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
934,645
|
$4,645,186 | — | 13 Feb 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.1%
|
195,899
|
$1,320,360 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
179,456
|
$1,209,534 | — | 30 Sep 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.85%
|
150,000
|
$1,011,000 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.46%
|
81,184
|
$547,180 | — | 30 Sep 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
41,615
|
$280,485 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
37,181
|
$250,677 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
29,223
|
$196,963 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
13,179
|
$88,826 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0.02%
|
3,353
|
$22,599 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
3,289
|
$22,168 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
2,030
|
$13,682 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
1,706
|
$11,498 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,318
|
$9,000 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,182
|
$7,967 | — | 30 Sep 2023 | |
| JTC Employer Solutions Trustee Ltd |
13F
|
Company |
0.01%
|
1,106
|
$7,000 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
615
|
$4,145 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
431
|
$2,905 | — | 30 Sep 2023 | |
| Carmichael Hill & Associates, Inc. |
13F
|
Company |
0%
|
100
|
$674 | — | 30 Sep 2023 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0%
|
41
|
$276 | — | 30 Sep 2023 | |
| Annapolis Financial Services, LLC |
13F
|
Company |
0%
|
23
|
$156 | — | 30 Sep 2023 | |
| Fortis Group Advisors, LLC |
13F
|
Company |
0%
|
14
|
$94 | — | 30 Sep 2023 | |
| STUDIO INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0%
|
9
|
$61 | — | 30 Sep 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
8
|
$54 | — | 30 Sep 2023 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
3
|
$20 | — | 30 Sep 2023 | |
| COMERICA BANK |
13F
|
Company |
0%
|
1
|
$7 | — | 30 Sep 2023 | |
| Sandy Spring Bank |
13F
|
Company |
0%
|
1
|
$7 | — | 30 Sep 2023 |
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q4 2023
As of 31 Dec 2023,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
749,666 shares.
The largest 10 holders included
Ikarian Capital, LLC, VANGUARD GROUP INC, Sio Capital Management, LLC, BlackRock Inc., BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, and FMR LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
26
Q4 2023 holders
32
Holder diff
6
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.